Epigenetics Hormone Therapy Serine-Threonine Kinase Inhibitors Threonine-Tyrosine Kinase Inhibitors EGFR Tyrosine Kinase Inhibitors Wnt Signaling Inhibitors PARP Inhibitors Immune Checkpoint Inhibitors Immunotherapy BCL Inhibitors Cyclin Dependent Kinase Inhibitors Other Proteasome Inhibitors | Pancreatic Cancer | Small Cell Lung Cancer | Prostate Cancer | Neuroblastoma | Medulloblastoma | Rhabdomyosarcoma |
---|---|---|---|---|---|---|
binimetinib + encorafenib | ||||||
AZD1775 | ||||||
enzalutamide capsule | ||||||
panobinostat + GSK2816126 | ||||||
OTX015 | ||||||
JQ-1 + panobinostat | ||||||
brigatinib | ||||||
crizotinib | ||||||
sonidegib | ||||||
olaparib + MK-8776 | ||||||
venetoclax + LY3295668 | ||||||
KB-0742 | ||||||
selinexor + VIP152 | ||||||
bortezomib + VIP152 | ||||||
VIP152 | ||||||
carfilzomib + VIP152 | ||||||
abiraterone acetate | ||||||
DHODH inhibitor |